| MeSH term | MeSH ID | Detail |
|---|---|---|
| Leukemia, Myelomonocytic, Acute | D015479 | 6 associated lipids |
| Uveal Neoplasms | D014604 | 3 associated lipids |
| Opioid-Related Disorders | D009293 | 5 associated lipids |
| Neuroendocrine Tumors | D018358 | 4 associated lipids |
| Sciatic Neuropathy | D020426 | 13 associated lipids |
| Adenocarcinoma, Papillary | D000231 | 2 associated lipids |
| von Hippel-Lindau Disease | D006623 | 1 associated lipids |
| Cystadenocarcinoma, Mucinous | D018282 | 1 associated lipids |
| Cystadenocarcinoma, Serous | D018284 | 2 associated lipids |
| Thyroid Hormone Resistance Syndrome | D018382 | 1 associated lipids |
| Carcinoma, Papillary, Follicular | D018265 | 1 associated lipids |
| Conjunctival Neoplasms | D003230 | 3 associated lipids |
| Classical Lissencephalies and Subcortical Band Heterotopias | D054221 | 1 associated lipids |
| Neoplasm Micrometastasis | D061206 | 1 associated lipids |
| Intervertebral Disc Degeneration | D055959 | 1 associated lipids |
| Ganglioneuroma | D005729 | 2 associated lipids |
| Fibromatosis, Aggressive | D018222 | 2 associated lipids |
| Chromosome Inversion | D007446 | 1 associated lipids |
| Gestational Trophoblastic Disease | D031901 | 1 associated lipids |
| Lupus Vulgaris | D008177 | 1 associated lipids |
trichostatin A
Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.
Cross Reference
Introduction
To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with trichostatin A?
trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with trichostatin A
PubChem Associated disorders and diseases
What pathways are associated with trichostatin A
Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with trichostatin A?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with trichostatin A?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with trichostatin A?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with trichostatin A?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with trichostatin A?
Mouse Model
Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).
Xenograft Model
Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).
Cancer Model
Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with trichostatin A
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Patel V et al. | Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. | 2009 | J. Med. Chem. | pmid:19317450 |
| Olsen CA and Ghadiri MR | Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides. | 2009 | J. Med. Chem. | pmid:19705846 |
| Trapp J et al. | Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition. | 2006 | J. Med. Chem. | pmid:17149860 |
| Liu T et al. | Design and synthesis of a potent histone deacetylase inhibitor. | 2007 | J. Med. Chem. | pmid:17419603 |
| Ragno R et al. | 3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studies. | 2004 | J. Med. Chem. | pmid:14998325 |
| Remiszewski SW et al. | Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates. | 2002 | J. Med. Chem. | pmid:11831887 |
| Baud MG et al. | Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets. | 2012 | J. Med. Chem. | pmid:22280363 |
| Remiszewski SW et al. | N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824). | 2003 | J. Med. Chem. | pmid:14521422 |
| Massa S et al. | Synthesis and antimicrobial and cytotoxic activities of pyrrole-containing analogues of trichostatin A. | 1990 | J. Med. Chem. | pmid:2213836 |
| Huber K et al. | Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins). | 2010 | J. Med. Chem. | pmid:20030343 |
| Trunzer M et al. | Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation. | 2009 | J. Med. Chem. | pmid:19108654 |
| Wittich S et al. | Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells. | 2002 | J. Med. Chem. | pmid:12109913 |
| Heltweg B et al. | Subtype selective substrates for histone deacetylases. | 2004 | J. Med. Chem. | pmid:15456267 |
| Paris M et al. | Histone deacetylase inhibitors: from bench to clinic. | 2008 | J. Med. Chem. | pmid:18247554 |
| Casero RA and Woster PM | Recent advances in the development of polyamine analogues as antitumor agents. | 2009 | J. Med. Chem. | pmid:19534534 |
| Mai A et al. | Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation, growth inhibition, and terminal cell differentiation. | 2002 | J. Med. Chem. | pmid:11960489 |
| Woo SH et al. | Structurally simple trichostatin A-like straight chain hydroxamates as potent histone deacetylase inhibitors. | 2002 | J. Med. Chem. | pmid:12061890 |
| Chen Y et al. | A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum. | 2008 | J. Med. Chem. | pmid:18494463 |
| Day JA and Cohen SM | Investigating the selectivity of metalloenzyme inhibitors. | 2013 | J. Med. Chem. | pmid:24074025 |
| Mai A et al. | Discovery of (aryloxopropenyl)pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A. | 2003 | J. Med. Chem. | pmid:14584932 |
| Neelarapu R et al. | Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes. | 2011 | J. Med. Chem. | pmid:21548582 |
| Suzuki T et al. | Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate. | 2006 | J. Med. Chem. | pmid:16884291 |
| Lopez-Atalaya JP et al. | Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome. | 2012 | J. Med. Genet. | pmid:21984751 |
| Malone CS et al. | B29 gene silencing in pituitary cells is regulated by its 3' enhancer. | 2006 | J. Mol. Biol. | pmid:16920149 |
| Lee JH et al. | Structural and functional studies of the yeast class II Hda1 histone deacetylase complex. | 2009 | J. Mol. Biol. | pmid:19573535 |
| Sawarkar R et al. | Histone deacetylases regulate multicellular development in the social amoeba Dictyostelium discoideum. | 2009 | J. Mol. Biol. | pmid:19576222 |
| Rincón-Arano H et al. | YY1 and GATA-1 interaction modulate the chicken 3'-side alpha-globin enhancer activity. | 2005 | J. Mol. Biol. | pmid:15913647 |
| Kee HJ and Kook H | Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. | 2009 | J. Mol. Cell. Cardiol. | pmid:19729022 |
| Kong X et al. | HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells. | 2009 | J. Mol. Cell. Cardiol. | pmid:19041327 |
| Sibinga NE | Stable protein, unstable plaque? | 2009 | J. Mol. Cell. Cardiol. | pmid:19101562 |
| Aune SE et al. | Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion. | 2014 | J. Mol. Cell. Cardiol. | pmid:24632412 |
| Liu F et al. | Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. | 2008 | J. Mol. Cell. Cardiol. | pmid:18926829 |
| Van Wagoner DR and Nattel S | Insights into mechanisms linking cardiac hypertrophy and atrial fibrosis: evidence for a role of histone deacetylase in atrial fibrillation pathophysiology and therapy. | 2008 | J. Mol. Cell. Cardiol. | pmid:18817781 |
| Margueron R et al. | Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens. | 2004 | J. Mol. Endocrinol. | pmid:15072561 |
| Nygård M et al. | Thyroid hormone-mediated negative transcriptional regulation of Necdin expression. | 2006 | J. Mol. Endocrinol. | pmid:16720720 |
| Ching LY et al. | Synergistic effect of p53 on TSA-induced stanniocalcin 1 expression in human nasopharyngeal carcinoma cells, CNE2. | 2012 | J. Mol. Endocrinol. | pmid:22493143 |
| Jaffe RC et al. | Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression. | 2007 | J. Mol. Endocrinol. | pmid:17339403 |
| Feng L et al. | Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells. | 2013 | J. Mol. Med. | pmid:22763818 |
| Her S et al. | Trichostatin A stimulates steroid 5alpha-reductase gene expression in rat C6 glioma cells via a mechanism involving Sp1 and Sp3 transcription factors. | 2010 | J. Mol. Neurosci. | pmid:19728174 |
| Sharma S et al. | Histone deacetylase inhibitor, trichostatin A, improves learning and memory in high-fat diet-induced cognitive deficits in mice. | 2015 | J. Mol. Neurosci. | pmid:25391764 |
| Jang BG et al. | Trichostatin A and Sirtinol Regulate the Expression and Nucleocytoplasmic Shuttling of Histone Deacetylases in All-Trans Retinoic Acid-Induced Differentiation of Neuroblastoma Cells. | 2018 | J. Mol. Neurosci. | pmid:29516351 |
| Wang Y et al. | Inhibition of histone deacetylase in the basolateral amygdala facilitates morphine context-associated memory formation in rats. | 2015 | J. Mol. Neurosci. | pmid:24829091 |
| Itoh M et al. | Trichostatin A enhances glutamate transporter GLT-1 mRNA levels in C6 glioma cells via neurosteroid-mediated cell differentiation. | 2013 | J. Mol. Neurosci. | pmid:22711563 |
| Sassi Fde A et al. | Inhibitory activities of trichostatin a in U87 glioblastoma cells and tumorsphere-derived cells. | 2014 | J. Mol. Neurosci. | pmid:24464841 |
| Alvarez AA et al. | The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells. | 2015 | J. Mol. Neurosci. | pmid:24874578 |
| Hosoya T et al. | Trichostatin analogues JBIR-109, JBIR-110, and JBIR-111 from the marine sponge-derived Streptomyces sp. RM72. | 2012 | J. Nat. Prod. | pmid:22276693 |
| Chen IH et al. | Cytotoxic triterpenoids from the stems of Microtropis japonica. | 2009 | J. Nat. Prod. | pmid:19534471 |
| Park JW et al. | Microbial transformation of trichostatin A to 2,3-dihydrotrichostatin A. | 2011 | J. Nat. Prod. | pmid:21504214 |
| Knobbe CB et al. | Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas. | 2004 | J. Natl. Cancer Inst. | pmid:15026474 |
| Tada Y et al. | Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. | 2006 | J. Natl. Cancer Inst. | pmid:16537832 |
| Boutillier AL et al. | Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis. | 2003 | J. Neurochem. | pmid:12562525 |
| Soriano FX et al. | SMRT-mediated co-shuttling enables export of class IIa HDACs independent of their CaM kinase phosphorylation sites. | 2013 | J. Neurochem. | pmid:23083128 |
| Meisel A et al. | Inhibition of histone deacetylation protects wild-type but not gelsolin-deficient neurons from oxygen/glucose deprivation. | 2006 | J. Neurochem. | pmid:16895577 |
| Lemonde S et al. | Cell type-dependent recruitment of trichostatin A-sensitive repression of the human 5-HT1A receptor gene. | 2004 | J. Neurochem. | pmid:14756806 |
| Host L et al. | Inhibition of histone deacetylases in rats self-administering cocaine regulates lissencephaly gene-1 and reelin gene expression, as revealed by microarray technique. | 2010 | J. Neurochem. | pmid:20132486 |
| Chen FQ et al. | Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea. | 2009 | J. Neurochem. | pmid:19141081 |
| Nunes MJ et al. | Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription. | 2010 | J. Neurochem. | pmid:20096088 |
| Tian F et al. | Dynamic chromatin remodeling events in hippocampal neurons are associated with NMDA receptor-mediated activation of Bdnf gene promoter 1. | 2009 | J. Neurochem. | pmid:19476549 |
| Korutla L et al. | The POZ/BTB protein NAC1 interacts with two different histone deacetylases in neuronal-like cultures. | 2005 | J. Neurochem. | pmid:16033423 |
| Crandall JE et al. | Retinoic acid influences neuronal migration from the ganglionic eminence to the cerebral cortex. | 2011 | J. Neurochem. | pmid:21895658 |
| Laeng P et al. | The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. | 2004 | J. Neurochem. | pmid:15379904 |
| Li Y et al. | Regulation of neuronal nitric oxide synthase exon 1f gene expression by nuclear factor-kappaB acetylation in human neuroblastoma cells. | 2007 | J. Neurochem. | pmid:17250678 |
| McKenzie GJ et al. | Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. | 2005 | J. Neurochem. | pmid:15773917 |
| Pazmany T and Tomasi TB | The major histocompatibility complex class II transactivator is differentially regulated by interferon-gamma and transforming growth factor-beta in microglial cells. | 2006 | J. Neuroimmunol. | pmid:16360884 |
| Camelo S et al. | Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. | 2005 | J. Neuroimmunol. | pmid:15885809 |
| Bajbouj K et al. | P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells. | 2012 | J. Neurooncol. | pmid:22270849 |
| Unland R et al. | Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system. | 2014 | J. Neurooncol. | pmid:24264533 |
| Li L et al. | Regulation of histone acetylation by NDRG2 in glioma cells. | 2012 | J. Neurooncol. | pmid:21912936 |
| Vecsey CG et al. | Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. | 2007 | J. Neurosci. | pmid:17553985 |
| Dagnas M et al. | HDAC inhibition facilitates the switch between memory systems in young but not aged mice. | 2013 | J. Neurosci. | pmid:23365234 |
| Marin-Husstege M et al. | Histone deacetylase activity is necessary for oligodendrocyte lineage progression. | 2002 | J. Neurosci. | pmid:12451133 |
| Sudo H and Baas PW | Acetylation of microtubules influences their sensitivity to severing by katanin in neurons and fibroblasts. | 2010 | J. Neurosci. | pmid:20505088 |
| Bates EA et al. | Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. | 2006 | J. Neurosci. | pmid:16525063 |
| Choi DC et al. | MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA. | 2014 | J. Neurosci. | pmid:25232110 |
| Liesz A et al. | Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. | 2013 | J. Neurosci. | pmid:24174668 |
| Leng Y and Chuang DM | Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. | 2006 | J. Neurosci. | pmid:16837598 |
| Romieu P et al. | Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. | 2008 | J. Neurosci. | pmid:18799668 |
| Pandey SC et al. | Brain chromatin remodeling: a novel mechanism of alcoholism. | 2008 | J. Neurosci. | pmid:18385331 |
| Dompierre JP et al. | Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. | 2007 | J. Neurosci. | pmid:17392473 |
| Wallace DM and Cotter TG | Histone deacetylase activity in conjunction with E2F-1 and p53 regulates Apaf-1 expression in 661W cells and the retina. | 2009 | J. Neurosci. Res. | pmid:18951482 |
| GarcÃa-Villegas R et al. | Identification and functional characterization of the promoter of the mouse sodium-activated sodium channel Na(x) gene (Scn7a). | 2009 | J. Neurosci. Res. | pmid:19326446 |
| Morita K et al. | Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells. | 2009 | J. Neurosci. Res. | pmid:19360904 |
| Kannan V et al. | Histone deacetylase inhibitors suppress immune activation in primary mouse microglia. | 2013 | J. Neurosci. Res. | pmid:23686642 |
| Wetzel M et al. | Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis. | 2005 | J. Neurosurg. | pmid:16383255 |
| Danaher RJ et al. | Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. | 2005 | J. Neurovirol. | pmid:16036811 |
| Li G et al. | Short-chain fatty acids enhance adipocyte differentiation in the stromal vascular fraction of porcine adipose tissue. | 2014 | J. Nutr. | pmid:25320182 |
| Strobl JS et al. | Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro. | 2007 | J. Parasitol. | pmid:17626366 |
| Zhang C et al. | Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. | 2007 | J. Pathol. | pmid:17471463 |
| Hamner JB et al. | The efficacy of combination therapy using adeno-associated virus--interferon beta and trichostatin A in vitro and in a murine model of neuroblastoma. | 2008 | J. Pediatr. Surg. | pmid:18206478 |
| Kim HJ et al. | Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17371805 |
| Zhang L et al. | Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. | 2012 | J. Pharmacol. Exp. Ther. | pmid:22271820 |
| Mateen S et al. | Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells. | 2013 | J. Pharmacol. Exp. Ther. | pmid:23461975 |
| Zheng C et al. | Histone Deacetylase Inhibitors Relax Mouse Aorta Partly through Their Inhibitory Action on L-Type Ca Channels. | 2017 | J. Pharmacol. Exp. Ther. | pmid:28860353 |
| Elaut G et al. | A metabolic screening study of trichostatin A (TSA) and TSA-like histone deacetylase inhibitors in rat and human primary hepatocyte cultures. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17218485 |
| Dong G et al. | Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents. | 2008 | J. Pharmacol. Exp. Ther. | pmid:18310471 |
| Fishel ML et al. | Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15304523 |
| Hu E et al. | Identification of novel isoform-selective inhibitors within class I histone deacetylases. | 2003 | J. Pharmacol. Exp. Ther. | pmid:12975486 |
| Tsuji M et al. | Epigenetic regulation of resistance to emotional stress: possible involvement of 5-HT1A receptor-mediated histone acetylation. | 2014 | J. Pharmacol. Sci. | pmid:25048113 |
| Koriyama Y et al. | Neuritogenic activity of trichostatin A in adult rat retinal ganglion cells through acetylation of histone H3 lysine 9 and RARβ induction. | 2014 | J. Pharmacol. Sci. | pmid:24389816 |
| Uchida H et al. | Histone deacetylase inhibitors relieve morphine resistance in neuropathic pain after peripheral nerve injury. | 2015 | J. Pharmacol. Sci. | pmid:26318673 |